Live feed
Filing
SC 13G
SC 13G0001393825-17-000006·Armata Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
AMPLIPHI BIOSCIENCES CORP
Security class unavailable · CUSIP: 03211P202
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,241,489
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001393825-17-000006
- Form type
- SC 13G
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Jan 30, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership